#ChoiceBroking #MorningTea

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
State-run power equipment maker BHEL has commissioned another 195 MW unit at Muzaffarpur thermal power station in Bihar.
This is the second 195 MW unit to be commissioned by BHEL at the 2x195 MW Muzaffarpur Thermal Power Station Stage-II of
Kanti Bijlee Utpadan Nigam Limited (KBUNL), a joint venture of NTPC and BSPGCL, the company said in a press release. According
to the statement, the first 195 MW unit was commissioned in March, 2015. BHEL is the leading supplier of coal-based main plant
equipment to NTPC and its joint ventures, with an over 80 per cent share in their installed capacity.
Technical Outlook : On daily chart, stock has formed Bullish Harami candlestick which is a bullish reversal candlestick and
indicates for upside movement. Moreover, stock has been trading above its 100 day moving average which is placed at 119.75
level, which shows that near to short term trend is up and stock could accelerates its upside movement. A momentum indicator
RSI reading is at 49.85 level with positive crossover, which point out for positive breath in the stock. So for trading perspective,
one could Buy in the range 121-122 for Target of 126 with SL of 119.
BHEL
AUROPHARMA
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
15th June 2016
Buy in the range of 750 -745 for the Target of 775 with the SL of 735
Buy in the range of 121-122 for the Target of 126 with the SL of 119
The government of India on Tuesday announced it has approved two foreign direct investment (FDI) proposals amounting to Rs
2.19 crore following the recommendations of foreign investment promotion board. It has also recommended one proposal for
approval of the Cabinet Committee on Economic Affairs. One of the proposals includes Aurobindo Pharma application for
approval of grant of ESOPs to non-resident employee of the company, while in the other Sterling Commerce seeking approval for
acting as an Investing company for Curan software international Private Limited.
Technical Outlook : From relative strength perspective Auro pharma remain strong counter among its pharma peers. Srocjh has
formed bullish candle at 250 day long term moving averagre, it shows stock is paying respect to its support area. In yesterdays
move stock has given close above 100 day moving average. Momentum oscillator RSI tested 40 level which has tracj record of
reversal area. Based on above rational one could buy in the range of 750 to 745 for the target of 775 with SL of 735.
Asian shares were slightly weaker but recovered from near three-week lows on Wednesday as markets digested US index
provider MSCI's decision not to include domestic Chinese equities in its indexes and Brexit fears drove investors to assets such as
US bonds and the yen. Mainland Chinese shares, among Asia's worst performers this year, were mixed while Hong Kong slid, as
markets, which had expected Chinese A-shares to be included in the emerging market index, considered the announcement.
MSCI's broadest index of Asia-Pacific shares outside Japan were down 0.1 percent. Japan's Nikkei reversed earlier losses to rise
0.7 percent. China's CSI 300 index and the Shanghai Composite staged a turnaround from earlier declines to rise 0.4 percent and
0.6 percent respectively. Hong Kong's Hang Seng index slipped 0.1 percent.
Global markets are jittery as investors are keenly waiting for the Federal Reserve decision on rates and Bank of Japan policy
meeting outcome while upcoming vote on whether the UK will remain in the European Union looms large. Indian market is seen
to be volatile on Wednesday waiting for global triggers to play out and hopes of a full monsoon which is already delayed. The IMD
has said Konkan region is seeing good pre-monsoon showers. It will be crucial for the Nifty to protect 8100 today. Bulls showed
resilience on Dalal Street once again yesterday amid global market sell-off. The 30-share BSE Sensex declined 1.06 points to
26395.71. The 50-share NSE Nifty managed to hold 8100 level, down 1.75 points at 8108.85 while the broader markets
outperformed benchmarks.

2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
15th June 2016
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 14/06/2016 500390 RELINFRA HSBC BANK (MAURITIUS) LIMITED S 2657142 541.50
2 14/06/2016 500390 RELINFRA AGF EMERGING MARKETS FUND B 2657142 541.50
3 14/06/2016 532980 GOKUL BALVANTSINH CHANDANSINH RAJPUT B 2500000 15.96
4 14/06/2016 532980 GOKUL KANUBHAI JIVATRAMTHAKKAR S 2500000 15.96
5 14/06/2016 539725 GOKULAGRO BALVANTSINH CHANDANSINH RAJPUT S 2500000 15.50
6 14/06/2016 539725 GOKULAGRO KANUBHAI JIVATRAMTHAKKAR B 2500000 15.50
7 14/06/2016 533239 PRAKASHSTL JMP SECURITIES PVT LTD B 880500 2.13
8 14/06/2016 513519 PITTILAM RUPESH BHAIDAS MEHTA S 283367 36.10
9 14/06/2016 513519 PITTILAM DHIREN SHEVANTILAL SHAH B 282767 36.10
10 14/06/2016 532813 CANDC L AND T INFRASTRUCTURE FINANCE COMPANY S 202834 11.72
Corporate Action:
Sterlite Technologies Limited; Sheme Of Arrangement
Bharti Infratel Limited; Buy-Back Of Shares
Oriental Bank of Commerce; Annual General Meeting/Dividend Re 0.70 Per Share
Result Calendar:
Corporate Action / Result Calendar
CANBK, INDIACEM & RCOM

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
15th June 2016
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kapil Shah
Digitally signed by Kapil Shah
DN: cn=Kapil Shah, o=Choice Equity Pvt Ltd,
ou=Research Team,
email=kapil.shah@choiceindia.com, c=US
Date: 2016.06.15 08:57:52 +05'30'